MedPath

A single center non randomized open-label comparative study using historical controls to verify the effectiveness of plasma exchange therapy for patients with anti-MDA 5 antibody positive rapidly progressive interstitial pneumonia

Not Applicable
Conditions
Interstitial pneumonia
Registration Number
JPRN-UMIN000032000
Lead Sponsor
Juntendo university
Brief Summary

o entry.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

When there is withdrawal of consent of research cooperation from research subjects. When the whole research is canceled. In cases where the researcher judges that the cancellation of research is appropriate for other reasons. When adverse reactions with difficult plasma continuation therapy appear.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
One year survival rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath